Brief: Ginkgo Bioworks Reports Fourth Quarter And Full Year 2025 Financial Results
26/02/2026 23:17
Feb 26 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N: GINKGO BIOWORKS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS, ANNOUNCES FOCUS ON AUTONOMOUS LABS OFFERINGS AND DIVESTITURE OF ITS NON-CORE BIOSECURITY BUSINESS Source text: ID:nPn4RtdMka Further company coverage: DNA.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ginkgo Bioworks Holdings
See all newsUS STOCKS ON THE MOVE-NiSource, Hewlett Packard, Sandisk
US STOCKS ON THE MOVE-CoreWeave, Moderna, Fox Corp
Brief: Ginkgo Bioworks To Provide Autonomous Lab Access To Nsf X-Labs Researchers
US weighs allowing most pharma licensing deals with China, sources say
Ginkgo Bioworks Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary